Miromatrix Medical Inc. (MIRO) Tops Q4 EPS by 12c

Miromatrix Medical Inc. (NASDAQ: MIRO) reported Q4 EPS of ($0.33), $0.12 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $930 thousand versus the consensus estimate of $3.5 thousand.

For earnings history and earnings-related data on Miromatrix Medical Inc. (MIRO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance